The sales for the September 2017 quarter moved up 28.57% to Rs. 18.54 millions as compared to Rs. 14.42 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2017 is Rs. -0.34 millions as compared to Net Profit of Rs. 0.01 millions of corresponding quarter ended September 2016Operating profit Margin for the quarter ended September 2017 slipped to -0.72% as compared to 0.08% of corresponding quarter ended September 2016 (Rs. in Million) Quarter ended Year to Date Year ended 201709 201609 % Var 201709 201609 % Var 201703 201603 % Var Sales 18.54 14.42 28.57 39.02 23.37 66.97 61.79 20.62 199.66 Other Income 0.04 0.16 -75.00 0.08 0.35 -77.14 0.01 0.02 -50.00 PBIDT -0.72 0.08 -1000.00 -1.51 -0.58 160.34 -1.63 -1.22 33.61 Interest 0.01 0.04 -75.00 0.02 0.11 -81.82 0.13 0.28 -53.57 PBDT -0.73 0.04 -1925.00 -1.53 -0.69 121.74 -1.76 -1.50 17.33 Depreciation 0.04 0.03 33.33 0.08 0.07 14.29 0.15 0.18 -16.67 PBT -0.77 0.01 -7800.00 -1.61 -0.76 111.84 -1.91 -1.68 13.69 TAX -0.43 0.00 0.00 -0.43 0.00 0.00 -0.59 -0.14 321.43 Deferred Tax -0.35 0.00 0.00 -0.35 0.00 0.00 -0.59 -0.14 321.43 PAT -0.34 0.01 -3500.00 -1.18 -0.76 55.26 -1.32 -1.54 -14.29 Equity 17.26 17.26 0.00 17.26 17.26 0.00 17.26 17.26 0.00 PBIDTM(%) -3.88 0.55 -799.98 -3.87 -2.48 55.93 -2.64 -5.92 -55.41

Sarda Proteins has informed about the details of Voting results at the 25th Annual General Meeting (AGM) of the Company held on September 20, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizers Report.The above information is a part of company’s filings submitted to BSE.

Sarda Proteins has informed about Standalone Financial Results and Limited Review for the period ended June 30, 2016.The above information is a part of company’s filings submitted to BSE.

Sarda Proteins has informed that Jyoti Soni the Company Secretary (KMP) has tendered her resignation received by the Company on May 26, 2016 and the same has been accepted.The above information is a part of company’s filings submitted to BSE.

Sarda Proteins has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The above information is a part of company’s filings submitted to BSE.

Sarda Proteins has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2015, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The above information is a part of company’s filings submitted to BSE.

Sarda Proteins has informed that due to death of mother of undersigned, who was also relative of two other directors, it was difficult the conduct AGM of the Company on or before September 30, 2015 the last due date for AGM.Therefore the Company applied to Registrar of Companies, Rajasthan for extension of time limit for AGM which was granted by ROC for two months. ROC, Rajasthan has extended the time to hold AGM for the year ended on March 31, 2015 till November 30, 2015.The above information is a part of company’s filings submitted to BSE.

Sarda Proteins has informed that in compliance with Corporate Governance SEBI circular regarding appointment of a Woman Director in the board of directors, the Company have appointed Krishna Devi Sarda as director of the Company with effect from March 23, 2015.The above information is a part of company’s filings submitted to BSE.

Sarda Proteins has informed about the Standalone Financial Results for the period ended December 31, 2014.The above information is a part of company’s filings submitted to BSE.

Sarda Proteins has informed about the Financial Results for the period ended December 31, 2013.The above information is a part of company’s filings submitted to BSE.

Sarda Proteins has informed that in the Extra Ordinary General Meeting of the company held on December 05, 2013 the members have passed the resolution to appoint Khetawat Agarwal & company, Alwar as statutory auditors of the company for financial year 2013-14.The above information is a part of company’s filings submitted to BSE.

Sarda Proteins has informed that the register of members & share transfer books of the company will remain closed from September 28, 2012 to September 29, 2012 for the purpose of annual general meeting (AGM) of the company.The above information is a part of company's filings submitted to BSE.